Cinarium Clindamycin Phosphate Injection I.P. 150mg/1ml (4ml)

Back to Medicines
Cinarium Clindamycin Phosphate Injection I.P. 150mg/1ml (4ml), image 1

Quality Assurance & Dispatch

WHO-GMP Standard
Cold Chain Logistics
Hospital Procurement
Pan-India Supply
Critical CareInjectionsInjectionIn StockRx Prescription Only

Cinarium Clindamycin Phosphate Injection I.P. 150mg/1ml (4ml)

Brand: Cinarium-150SKU: CC06
Maximum Retail Price (MRP)
₹200(Inclusive of all taxes)
Bulk Hospital Pricing on Enquiry

Product Summary

Cinarium-150 Clindamycin Phosphate Injection IP 150mg/ml is a prescription antibiotic used for serious bacterial infections, including skin, respiratory, bone, joint and intra-abdominal infections. Available in 4ml × 5 glass ampoules (600mg per ampoule) for IM/IV use. Essentials Emporium Enterprises supplies Clindamycin Injection 150mg/ml and hospital antibiotics to authorised pharmaceutical distributors and healthcare institutions across India.

Dosage FormInjection
Therapy AreaCritical care
PackagingCinarium-150 Clindamycin Phosphate Injection IP 150 mg/ml, containing 600 mg per 4 ml glass ampoule. Pack size: 5 × 4 ml ampoules per box. Prescription antibiotic injection.
CategoryCritical Care
Quantity:
1
Proceed to Checkout

Cinarium-150 Clindamycin Phosphate Injection I.P. 150 mg/ml is a prescription antibiotic injection used in the treatment of serious bacterial infections caused by susceptible microorganisms. It contains Clindamycin Phosphate, a lincosamide antibiotic that works by inhibiting bacterial protein synthesis, helping control bacterial growth and infection.

Clindamycin Injection 150 mg/ml is used in hospitals, intensive care units (ICUs), surgical departments and other healthcare facilities for the management of selected respiratory tract infections, skin and soft tissue infections, bone and joint infections, intra-abdominal infections and pelvic infections when clinically indicated.

Cinarium-150 is supplied in 4 ml glass ampoules, each containing 600 mg of Clindamycin, with a pack size of 5 × 4 ml ampoules. The product is intended for intramuscular (IM) or intravenous (IV) administration by qualified healthcare professionals. Intravenous administration requires appropriate dilution and infusion according to approved prescribing instructions.

Essentials Emporium Enterprises markets Cinarium-150 for hospitals, healthcare institutions, pharmaceutical distributors and authorized bulk medicine procurement across India.

Key Features

Brand NameCinarium-150
Generic NameClindamycin Phosphate Injection I.P.
Strength150 mg/ml
Total Drug Content600 mg per 4 ml ampoule
Dosage FormInjectable Solution
Drug CategoryLincosamide Antibiotic
Packaging TypeGlass Ampoules
Ampoule Volume4 ml
Pack Size5 × 4 ml Ampoules
Administration RouteIntramuscular (IM) / Intravenous (IV)
Pharmacopoeial StandardIndian Pharmacopoeia (I.P.)
ApplicationHospital Antibiotic Therapy and Management of Susceptible Bacterial Infections
StorageStore below 25°C, protected from light. Do not freeze.
Prescription StatusSchedule H Prescription Drug

Composition

Each ml contains:

Clindamycin Phosphate I.P. equivalent to Clindamycin ........ 150 mg

Sterile Water for Injection I.P. ........ q.s.

Each 4 ml ampoule contains the equivalent of 600 mg Clindamycin.

Indications and Uses

Clindamycin Phosphate Injection may be prescribed for the treatment of susceptible bacterial infections, including:

Respiratory Tract InfectionsCertain serious bacterial infections affecting the lungs and respiratory system.
Skin and Soft Tissue InfectionsSelected infections involving skin, soft tissues and deeper structures.
Bone and Joint InfectionsTreatment of susceptible bacterial infections such as osteomyelitis.
Intra-Abdominal InfectionsUsed as part of appropriate antibiotic therapy for certain serious abdominal infections.

Pelvic and Gynecological Infections: Treatment of selected infections involving the female reproductive tract.

Serious Anaerobic Bacterial Infections: Management of infections caused by susceptible anaerobic organisms.

The choice of antibiotic should follow clinical assessment, local resistance patterns and appropriate microbiological testing where available.